Top Markets
Coin of the day
Brii Biosciences Limited Brii Biosciences Limited

Brii Biosciences Limited

2137
Peringkat dalam Saham #22138
Founded in Beijing, China, in 2017, Brii Biosciences Limited is a... Founded in Beijing, China, in 2017, Brii Biosciences Limited is a biopharmaceutical firm dedicated to discovering and developing innovative therapies for infectious diseases and central nervous system disorders. Its diverse pipeline features: early-stage (Phase 1) compounds BRII-778 and BRII-732 for treating HIV; a multifaceted approach to Hepatitis B (HBV) including a Phase 2 combination study of BRII-179 and BRII-835, with BRII-179 (a recombinant protein-based immunotherapeutic) also in Phase 1b/2a, and BRII-835 having successfully completed Phase 2 for chronic HBV patients. The company also offers the Amubarvimab/romlusevimab combination as a treatment for COVID-19. Beyond these, Brii Biosciences is advancing BRII-296 for PPD and BRII-297 for various depressive conditions, alongside several agents targeting highly resistant infections: BRII-636, BRII-672, and BRII-693 are designed to combat multi-drug and extensively drug-resistant (MDR/XDR) gram-negative bacteria, while BRII-658 is under development for MDR/XDR tuberculosis and non-tuberculosis mycobacterial infections.
Harga Saham
$0.12984512
Terakhir disinkronkan: 2026-08-21
Kapitalisasi Pasar
$93.64M
Perubahan (1 hari)
3.57%
Perubahan (1 tahun)
-49.27%
Negara
CN
Perdagangan Brii Biosciences Limited (2137)

Kategori

Riwayat harga saham Brii Biosciences Limited (2137)
Harga penutupan tertinggi: $0.12 pada 2026-08-01

Harga penutupan terendah: $2.91 pada 2021-07-01
Riwayat harga saham Brii Biosciences Limited dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -4.52%
2025 66.95%
2024 -60.43%
2023 -71.76%
2022 -77.93%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH